Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study.
Xinwei HuaJames Y DaiSara LindströmTabitha A HarrisonYi LinSteven R AlbertsElizabeth AlwersSonja I BerndtHermann BrennerDaniel D BuchananPeter T CampbellGraham CaseyJenny Chang-ClaudeSteven GallingerGraham G GilesRichard M GoldbergMarc J GunterMichael HoffmeisterMark A JenkinsAmit D JoshiWenjie MaJonathan BeesleyNeil MurphyRish K PaiLori C SakodaRobert E SchoenQian ShiMartha L SlatteryMingyang SongEmily WhiteLoic Le MarchandAndrew T ChanUlrike PetersPolly A NewcombPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Future research evaluating genetically determined levels of other circulating inflammatory biomarkers (i.e., IL6) with colorectal cancer survival outcomes is needed.
Keyphrases